Parexel International Corp (PRXL)-Financial and Strategic SWOT Analysis Review

Parexel International Corp (PRXL)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH63385FSA
  • |
  • Pages: 54
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Parexel International Corp (PRXL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Parexel International Corp (Parexel) is a biopharmaceutical outsourcing services company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.

Parexel International Corp Key Recent Developments

Nov 14, 2016: PAREXEL Launches IDMP-Focused Software and Service Solution

Oct 26, 2016: PAREXEL International Reports First Quarter Fiscal Year 2017 Results and Announces New Share Repurchase Program

Oct 06, 2016: PAREXEL Launches Active Tracking Service for Monitoring and Managing Temperature-Controlled Investigational Medicinal Products

Sep 19, 2016: Christian Dreger Joins PAREXEL as Senior Vice President, PAREXEL Access and PAREXEL Consulting

Aug 03, 2016: PAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Parexel International Corp-Key Facts 6

Parexel International Corp-Key Employees 7

Parexel International Corp-Key Employee Biographies 8

Parexel International Corp-Major Products and Services 9

Parexel International Corp-History 10

Parexel International Corp-Company Statement 16

Parexel International Corp-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Section 2-Company Analysis 23

Parexel International Corp-Business Description 23

Parexel International Corp-Corporate Strategy 24

Parexel International Corp-SWOT Analysis 25

SWOT Analysis-Overview 25

Parexel International Corp-Strengths 25

Parexel International Corp-Weaknesses 26

Parexel International Corp-Opportunities 27

Parexel International Corp-Threats 28

Parexel International Corp-Key Competitors 29

Section 3-Company Financial Ratios 30

Financial Ratios-Capital Market Ratios 30

Financial Ratios-Annual Ratios 31

Performance Chart 33

Financial Performance 33

Financial Ratios-Interim Ratios 34

Financial Ratios-Ratio Charts 35

Section 4-Company's Lifesciences Financial Deals and Alliances 36

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 36

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 37

Parexel International Corp, Recent Deals Summary 38

Section 5-Company's Recent Developments 39

Nov 14, 2016: PAREXEL Launches IDMP-Focused Software and Service Solution 39

Oct 26, 2016: PAREXEL International Reports First Quarter Fiscal Year 2017 Results and Announces New Share Repurchase Program 40

Oct 06, 2016: PAREXEL Launches Active Tracking Service for Monitoring and Managing Temperature-Controlled Investigational Medicinal Products 41

Sep 19, 2016: Christian Dreger Joins PAREXEL as Senior Vice President, PAREXEL Access and PAREXEL Consulting 42

Aug 03, 2016: PAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results 43

Aug 01, 2016: PAREXEL Appoints Four Executives to Senior Leadership Team 45

Jun 30, 2016: PAREXEL International Outlines Growth Strategy and Updates Financial Guidance at Investor Day 46

Jun 20, 2016: PAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016 47

Jun 10, 2016: PAREXEL Announces Master Services Agreement with Pfizer 48

Apr 27, 2016: PAREXEL International Reports Third Quarter Fiscal Year 2016 Results 49

Section 6-Appendix 50

Methodology 50

Ratio Definitions 50

About GlobalData 54

Contact Us 54

Disclaimer 54

List of Figures

Parexel International Corp, Performance Chart (2012-2016) 33

Parexel International Corp, Ratio Charts 35

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 36

Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 37

List of Tables

Parexel International Corp, Key Facts 6

Parexel International Corp, Key Employees 7

Parexel International Corp, Key Employee Biographies 8

Parexel International Corp, Major Products and Services 9

Parexel International Corp, History 10

Parexel International Corp, Other Locations 18

Parexel International Corp, Subsidiaries 19

Parexel International Corp, Key Competitors 29

Parexel International Corp, Ratios based on current share price 30

Parexel International Corp, Annual Ratios 31

Parexel International Corp (Cont...1), Annual Ratios 32

Parexel International Corp, Interim Ratios 34

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 36

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 37

Parexel International Corp, Recent Deals Summary 38

Currency Codes 50

Capital Market Ratios 50

Equity Ratios 51

Profitability Ratios 51

Cost Ratios 52

Liquidity Ratios 52

Leverage Ratios 52

Efficiency Ratios 53

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Worldwide Clinical Trials Drug Development Solutions Inc, Quintiles Transnational Holdings Inc, Quintiles Transnational Corp., Pharmaceutical Product Development LLC, Patheon Inc, Laboratory Corp of America Holdings, inVentiv Health Inc, INC Research LLC, ICON Plc, Covance Inc

Parexel International Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8871
Site License
USD 250 INR 17743
Corporate User License
USD 375 INR 26614

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com